Solubility and salting behavior of several β-adrenergic blocking agents in liquid and supercritical carbon dioxide

Journal of Chemical and Engineering Data

Volumn 50, Issue 1, 2005, Pages 226-229

  Weinstein, Randy D ^a   Gribbin, Joseph J ^a   Muske, Kenneth R ^a  

^a Villanova University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENTS; NADOLOL; PINDOLOL; SEPARATION TECHNIQUES;

AROMATIC COMPOUNDS; CARDIOVASCULAR SYSTEM; DATA REDUCTION; DISEASES; DRUG PRODUCTS; ISOMERS; SOLUBILITY; TISSUE;

CARBON DIOXIDE;

EID: 12344308312     PISSN: 00219568     EISSN: None     Source Type: Journal    
DOI: 10.1021/je0497202     Document Type: Article

References (19)

1. Connolly, M. E.; Kersting, F.; Dollery, C. T. The Clinical Pharmacology of Beta-Adrenoreceptor Blocking Drugs. Prog. Cardiovasc. Dis. 1976, 19, 203-234.
2. Radack, K. L.; Deck, C. C.; Bloomfield, S. S. Ibuprofen Interferes with the Efficacy of Antihypertensive Drugs. Ann. Intern. Med. 1987, 107, 628-635.
3. Brodsky, M. A.; Allen, B. J.; Luckett, C. R. Antiarrhythmic Efficacy of Solitary Beta-Adrenergic Blockade for Patienta with Sustained Ventricular Tachyarrhythmias. Am. Heart J. 1989, 118, 272-280.
4. Remuzzi, G.; Ruggenenti, P. Prevention and Treatment of Pregnancy-Associated Hypertension: What Have We Learned in the Last 10 Yean? Am. J. Kidney Dis. 1991, 18, 285-306.
5. Neau, S. H.; Shinwari, M. K; Hellmuth, W. W. Melting Point Phase Diagrams of Free Base and Rydrochloride Salts of Bevantolol, Pindolol, and Propranolol. Int. J. Pharm. 1983, 99, 303-310.
6. 126I-iodocyanopindolol Binding to β-Adrenergic and Serotonin-1B Receptors of Rat Brain: Selectivity of β-Adrenergic Agents. Jpn. J. Pharmacol. 1990, 52, 196-200.
7. Dayer, P.; Leeemann, T.; Gut, J.; Kronbach, T.; Kupfer, A.; Francis, R.; Meyer, U. Steric Configuration and Polymorphic Oxidation of Lipophilic Beta-Adrenergic Blocking Agents: In Vitro - In Vivo Correlations. Biochem. Pharmacol. 1985, 34, 399-400.
8. Foster, N.; Mammucari, R.; Dehghani, F.;Barrett,A.;Bezanehtak, K.; Coen, E.; Combes, G.; Meure, L.; Ng, A.; Regtop, H. L.; Tandya, A. Processing Pharmaceutical Compounds Using Dense Gas Technology. Ind. Eng. Chem. Res. 2003, 42, 6476-6493.
9. Geiser, F.; Shah, R. Enantioseparation of Hydrochloride Salts Using Carbon Dioxide-Based Mobile Phases with On-Line Polarimetric Detection. Chirality 2004, 16, 263-266.
10. Weinstein, R. D.; Muske, K. R.; Moriarty, J.; Schmidt, E. K. The Solubility of Benzocaine, Lidocaine, and Procaine in Liquid and Supercritical Carbon Dioxide. J. Chem. Eng. Data 2004, 49, 547-552.
11. Francis, A W. Ternary Systems of Liquid Carbon Dioxide. J. Phys. Chem. 1954, 58, 1099-1114.
12. Dandge, D. K.; Heller, J. P.; Wilson, K. V. Structure Solubility Correlations: Organic Compounds and Dense Carbon Dioxide Binary Systems. Ind. Eng. Chem. Prod. Res. Dev. 1985, 24, 162-166.
13. Macnaughton, S. J.; Kikic, I.; Foster, N. R.; Alessi, P.; Cortesi, A.; Colombo, I. Solubility of Anti-Inflammatory Drugs in Supercritical Carbon Dioxide. J. Chem. Eng. Data 1996, 41, 1083-1086.
14. 2 under Dynamic Conditions. J. Chem. Eng. Data 2000, 45, 161-165.
15. Lemmon, E. W.; Peskin, A. P.; McLinden, M. O.; Friend, D. G. NIST Thermodynamic and Transport Properties of Pure Fluids - NIST Pure Fluids Version 5.0. 2000; U.S. Secretary of Commerce Copyright.
16. Xing, H.; Yang, Y.; Su, B.; Huang, M.; Ren, Q. Solubility of Artemisinin in Supercritical Carbon Dioxide. J. Chem. Eng. Data 2003, 48, 330-332.
17. Raymond, G. G.; Born, J. L. An Updated pKa Luting of Medicinal Compounds. Drug Intell. Clin. Pharm. 1986, 20, 683-686.
18. Adson, A.; Burton, P. S.; Raub, T. J.; Barsuhn, C. L.; Audud, K. L.; Ho, N. F. H. Passive Diffusion of Weak Organic Electrolytes across Caco-2 Cell Monolayers: Uncoupling the Contributions of Hydrodynamics, Transcellular, and Paracellular Barriers. J. Pharm. Sci. 1995, 84, 1197-1204.
19. 2. Ind. Eng. Chem. Res. 2003, 42, 6415-6424.